Eterna Therapeutics
ERNA
#10404
Rank
S$18.3 M
Marketcap
S$15.69
Share price
-10.12%
Change (1 day)
251.20%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): S-$98.70

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is S-$98.26. In 2022 the company made an earnings per share (EPS) of S-$161.20 an increase over its 2021 EPS that were of S-$1,065.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$98.70
2022S-$161.20-84.86%
2021S-$1,065

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
S$3.28-103.34%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
S-$2.73-97.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
S-$2.59-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S-$0.17-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
S$1.75-101.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
S$0.91-100.93%๐Ÿ‡บ๐Ÿ‡ธ USA